Beth Gustafson
Papers
1
Total Citations
9
H-Index
1
About
Beth Gustafson is a clinical researcher whose work centers on precision oncology and the application of targeted therapies in gastrointestinal malignancies. Her major contributions lie in identifying actionable mutations beyond traditional indications, most notably demonstrated in her landmark case report on a colorectal cancer patient harboring an *EGFR* T790M mutation—a finding typically associated with lung cancer. By documenting a successful response to osimertinib in this novel context, Gustafson has expanded the therapeutic landscape for colorectal cancer, highlighting the power of genomic profiling in guiding treatment decisions. This work, which has garnered 9 citations, underscores her impact in bridging molecular biology and clinical practice. Additionally, her research explores the evolving role of minimally invasive surgical techniques, including laparoscopic and robotic approaches, in complex oncologic resections. Through her case-based investigations and translational focus, Gustafson has contributed to a more nuanced understanding of how targeted agents can be repurposed across tumor types, offering new hope for patients with refractory disease and advancing the paradigm of personalized cancer care.
Research Focus
Key Achievements
Top Papers
- 1